Eun-Yong Choi

Title: Eun-Yong Choi: Innovator in Immunoadhesion Molecules

Introduction

Eun-Yong Choi is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of concatameric immunoadhesion molecules. With a total of 3 patents to his name, Choi's work is paving the way for advancements in pharmaceutical and diagnostic compositions.

Latest Patents

Choi's latest patents include innovative technologies related to polynucleotides encoding concatameric immunoadhesion molecules. These patents disclose concatameric proteins that consist of two soluble domains. The C-terminus of a soluble domain of a biologically active protein is linked to the N-terminus of either an identical or distinct soluble domain. Furthermore, the patents describe dimeric proteins formed through intermolecular disulfide bonds at the hinge region of two monomeric proteins. These proteins are linked by a concatamer of two identical soluble extracellular regions, which are involved in immune responses to an Fc fragment of an immunoglobulin molecule. The inventions also cover glycosylated proteins, DNA constructs encoding the monomeric proteins, and recombinant expression plasmids. Additionally, the patents outline methods for preparing dimeric proteins by culturing host cells transformed or transfected with the recombinant expression plasmids. The inventions culminate in pharmaceutical or diagnostic compositions that incorporate the dimeric protein or its glycosylated form.

Career Highlights

Eun-Yong Choi is currently associated with Medexgen Co., Ltd., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in medical treatments and diagnostics.

Collaborations

Choi collaborates with esteemed colleagues, including Yong-Hoon Chung and Ji-Woong Han, who contribute to his research endeavors.

Conclusion

Eun-Yong Choi's contributions to the field of immunoadhesion molecules highlight his role as a leading inventor in biotechnology. His innovative patents are set to make a significant impact on pharmaceutical and diagnostic advancements.